| CNV | Copy number variation |
| CPTAC | Clinical Proteomic Tumor Analysis Consortium |
| DSS | Disease-specific survival |
| FIGO | Fédération Internationale de Gynécologie et d’Obstétrique |
| GDC | Genomic Data Commons |
| H&E | Hematoxylin and eosin |
| HPF | High-power field |
| LVSI | Lymphovascular space invasion |
| MELF | Microcystic, elongated, fragmented |
| MSI | Microsatellite instability |
| OS | Overall survival |
| PFS | Progression-free survival |
| POLE | Polymerase ε |
| TB | Tumor budding |
| TCGA | The Cancer Genome Atlas |
| TIL | Tumor infiltrating lymphocytes |
| TSR | Tumor–stroma ratio/stromal desmoplasia |
| UCEC | Uterine Corpus Endometrial Carcinoma |
| WHO | World Health Organization |